{"hands_on_practices": [{"introduction": "Before we can learn how to control for confounding, we must first appreciate the danger it poses. This exercise presents a classic case of Simpson's paradox, where an association observed in an entire population is reversed within its subgroups. By calculating the crude, marginal effect from hypothetical data, you will see firsthand how failing to account for a key variable like disease severity can lead to conclusions that are not just wrong, but potentially harmful [@problem_id:4973496].", "problem": "Consider an observational cohort study of hospitalized adults with community-acquired pneumonia evaluating the effect of an early broad-spectrum antibiotic ($T=1$) versus delayed or narrow-spectrum management ($T=0$) on a binary outcome of clinical recovery by day $30$ ($Y=1$ for recovery, $Y=0$ otherwise). Disease severity at admission is classified into two strata based on a validated severity index: stratum $\\mathcal{S}_{0}$ (milder presentation) and stratum $\\mathcal{S}_{1}$ (severe presentation). Severity is a potential confounder of the treatment-outcome relationship because it influences both treatment choice and prognosis.\n\nYou are given the following counts:\n\n- In stratum $\\mathcal{S}_{0}$: among the treated ($T=1$), $42$ of $50$ recovered; among the untreated ($T=0$), $320$ of $400$ recovered.\n- In stratum $\\mathcal{S}_{1}$: among the treated ($T=1$), $150$ of $600$ recovered; among the untreated ($T=0$), $18$ of $80$ recovered.\n\nUsing only fundamental probability definitions and without introducing untested modeling assumptions, compute the overall marginal risk difference, defined as\n$$ RD_{\\text{marginal}} \\equiv \\Pr(Y=1 \\mid T=1) - \\Pr(Y=1 \\mid T=0), $$\nwhen severity strata are ignored (that is, collapsed across $\\mathcal{S}_{0}$ and $\\mathcal{S}_{1}$). Express your answer as a decimal and round your final result to four significant figures.", "solution": "The objective is to compute the overall marginal risk difference, $RD_{\\text{marginal}}$, which quantifies the difference in the probability of recovery between the treated and untreated groups when the confounding variable, disease severity, is ignored. The definition is given as:\n$$\nRD_{\\text{marginal}} \\equiv \\Pr(Y=1 \\mid T=1) - \\Pr(Y=1 \\mid T=0)\n$$\nHere, $Y=1$ denotes recovery, $T=1$ denotes receiving the early broad-spectrum antibiotic treatment, and $T=0$ denotes the alternative management. The probabilities are estimated from the provided sample counts.\n\nThe problem requires us to collapse the data across the two severity strata, $\\mathcal{S}_{0}$ (milder) and $\\mathcal{S}_{1}$ (severe). We first aggregate the counts for the treated population ($T=1$) and the untreated population ($T=0$) across both strata.\n\nLet $N_{T=t, S=s}$ be the number of individuals and $C_{T=t, S=s}$ be the count of recovered individuals, for treatment status $t \\in \\{0, 1\\}$ and stratum $s \\in \\{0, 1\\}$.\n\nThe given data are:\nFor stratum $\\mathcal{S}_{0}$:\n- Treated ($T=1$): $C_{T=1, S=0} = 42$, $N_{T=1, S=0} = 50$.\n- Untreated ($T=0$): $C_{T=0, S=0} = 320$, $N_{T=0, S=0} = 400$.\n\nFor stratum $\\mathcal{S}_{1}$:\n- Treated ($T=1$): $C_{T=1, S=1} = 150$, $N_{T=1, S=1} = 600$.\n- Untreated ($T=0$): $C_{T=0, S=1} = 18$, $N_{T=0, S=1} = 80$.\n\nTo calculate the marginal probabilities, we first find the total counts for the entire study population, collapsed across strata.\n\nTotal number of recovered individuals in the treated group ($T=1$):\n$$\nC_{T=1} = C_{T=1, S=0} + C_{T=1, S=1} = 42 + 150 = 192\n$$\nTotal number of individuals in the treated group ($T=1$):\n$$\nN_{T=1} = N_{T=1, S=0} + N_{T=1, S=1} = 50 + 600 = 650\n$$\n\nTotal number of recovered individuals in the untreated group ($T=0$):\n$$\nC_{T=0} = C_{T=0, S=0} + C_{T=0, S=1} = 320 + 18 = 338\n$$\nTotal number of individuals in the untreated group ($T=0$):\n$$\nN_{T=0} = N_{T=0, S=0} + N_{T=0, S=1} = 400 + 80 = 480\n$$\n\nNow, we estimate the marginal probabilities (risks) of recovery for each treatment group using these aggregated counts.\n\nThe probability of recovery given treatment ($T=1$) is estimated as:\n$$\n\\Pr(Y=1 \\mid T=1) \\approx \\frac{C_{T=1}}{N_{T=1}} = \\frac{192}{650}\n$$\n\nThe probability of recovery given no treatment ($T=0$) is estimated as:\n$$\n\\Pr(Y=1 \\mid T=0) \\approx \\frac{C_{T=0}}{N_{T=0}} = \\frac{338}{480}\n$$\n\nFinally, we compute the marginal risk difference by subtracting the risk in the untreated group from the risk in the treated group:\n$$\nRD_{\\text{marginal}} \\approx \\frac{192}{650} - \\frac{338}{480}\n$$\nWe convert these fractions to their decimal representations for calculation:\n$$\n\\frac{192}{650} \\approx 0.2953846...\n$$\n$$\n\\frac{338}{480} = \\frac{169}{240} \\approx 0.7041666...\n$$\nThe risk difference is therefore:\n$$\nRD_{\\text{marginal}} \\approx 0.2953846 - 0.7041666 = -0.408782...\n$$\nThe problem requires the answer to be rounded to four significant figures. The first four significant figures are $4$, $0$, $8$, and $7$. The fifth significant figure is $8$, which is $\\ge 5$, so we round up the fourth significant figure.\n$$\nRD_{\\text{marginal}} \\approx -0.4088\n$$\nThis negative value indicates that in this crude, unadjusted analysis, the early broad-spectrum antibiotic treatment is associated with a substantially lower probability of recovery compared to the alternative management. This counterintuitive result is a classic example of confounding by indication (a form of Simpson's paradox), where the sickest patients are preferentially given the treatment being studied, making the treatment appear harmful when in fact it may be beneficial or neutral.", "answer": "$$\n\\boxed{-0.4088}\n$$", "id": "4973496"}, {"introduction": "Once a confounder has been identified, a common goal is to estimate what the effect of an exposure would be in a standardized population. This practice introduces direct standardization, a foundational technique in epidemiology to adjust for confounders like age. You will calculate an age-standardized risk difference based on hypothetical risks, providing a single summary measure of effect that is free from the confounding influence of the population's age structure [@problem_id:4549025].", "problem": "A public health department is evaluating the effect of an influenza vaccination program on the one-year risk of laboratory-confirmed influenza. Age is a known confounder. Investigators report stratum-specific one-year risks of influenza among vaccinated (exposed) and unvaccinated (unexposed) individuals across three age strata, and they provide the age distribution of a target population to which results should be directly standardized. Use the definition of risk as probability over a fixed period and the law of total probability as the fundamental base.\n\nData:\n- Age strata:\n  - Stratum $S_1$ (age  40 years): vaccinated risk $= 0.015$; unvaccinated risk $= 0.030$.\n  - Stratum $S_2$ (age $40$–$64$ years): vaccinated risk $= 0.040$; unvaccinated risk $= 0.060$.\n  - Stratum $S_3$ (age $\\ge 65$ years): vaccinated risk $= 0.090$; unvaccinated risk $= 0.140$.\n- Target population age distribution: $\\Pr(S_1) = 0.55$, $\\Pr(S_2) = 0.30$, $\\Pr(S_3) = 0.15$.\n\nTasks:\n1. Using direct standardization, compute the Directly Standardized Risk (DSR) for the vaccinated group, denoted $DSR_{\\text{vacc}}$, and for the unvaccinated group, denoted $DSR_{\\text{unvacc}}$, by weighting the stratum-specific risks by the target population distribution.\n2. Compute the Standardized Risk Difference (SRD), defined as $SRD = DSR_{\\text{vacc}} - DSR_{\\text{unvacc}}$.\n3. Briefly interpret the sign of the $SRD$ in words, focusing on whether the program increases or decreases risk after controlling for the age distribution of the target population.\n\nExpress the final numerical answer for $SRD$ as a decimal (not a percentage) and round to four significant figures.", "solution": "The core principle behind direct standardization is the law of total probability. The Directly Standardized Risk (DSR) for a given exposure group is the expected risk in a hypothetical population that has the stratum-specific risks of the exposure group but the population structure of a standard (or target) population.\n\nLet $E$ represent the exposure status, where $E=V$ for vaccinated and $E=U$ for unvaccinated. The stratum-specific risk in stratum $S_i$ for exposure status $E$ is $\\Pr(D|E, S_i)$. The proportion of the standard population in stratum $S_i$ is $\\Pr(S_i)$.\n\nThe formula for the DSR for exposure group $E$ is:\n$$DSR_E = \\sum_{i=1}^{3} \\Pr(D | E, S_i) \\Pr(S_i)$$\nThis gives the overall risk that would be observed in the standard population if everyone in it had the stratum-specific risks of the exposure group $E$.\n\n**1. Compute the Directly Standardized Risks ($DSR_{\\text{vacc}}$ and $DSR_{\\text{unvacc}}$)**\n\nFor the vaccinated group ($E=V$), the DSR is calculated by weighting the stratum-specific risks for the vaccinated by the standard population proportions:\n$$DSR_{\\text{vacc}} = \\Pr(D | V, S_1)\\Pr(S_1) + \\Pr(D | V, S_2)\\Pr(S_2) + \\Pr(D | V, S_3)\\Pr(S_3)$$\nSubstituting the given values:\n$$DSR_{\\text{vacc}} = (0.015)(0.55) + (0.040)(0.30) + (0.090)(0.15)$$\n$$DSR_{\\text{vacc}} = 0.00825 + 0.01200 + 0.01350$$\n$$DSR_{\\text{vacc}} = 0.03375$$\n\nFor the unvaccinated group ($E=U$), the DSR is calculated similarly:\n$$DSR_{\\text{unvacc}} = \\Pr(D | U, S_1)\\Pr(S_1) + \\Pr(D | U, S_2)\\Pr(S_2) + \\Pr(D | U, S_3)\\Pr(S_3)$$\nSubstituting the given values:\n$$DSR_{\\text{unvacc}} = (0.030)(0.55) + (0.060)(0.30) + (0.140)(0.15)$$\n$$DSR_{\\text{unvacc}} = 0.01650 + 0.01800 + 0.02100$$\n$$DSR_{\\text{unvacc}} = 0.05550$$\n\n**2. Compute the Standardized Risk Difference (SRD)**\n\nThe SRD is the difference between the two standardized risks:\n$$SRD = DSR_{\\text{vacc}} - DSR_{\\text{unvacc}}$$\n$$SRD = 0.03375 - 0.05550$$\n$$SRD = -0.02175$$\n\nThe problem requires the answer to be rounded to four significant figures. The calculated value, $-0.02175$, already has four significant figures (the digits $2$, $1$, $7$, and $5$). Therefore, no further rounding is necessary.\n\n**3. Interpret the sign of the SRD**\n\nThe computed SRD is negative ($-0.02175$). This indicates that $DSR_{\\text{vacc}}  DSR_{\\text{unvacc}}$. After controlling for the confounding effect of age by standardizing to the target population's age distribution, the one-year risk of laboratory-confirmed influenza is lower in the vaccinated group than in the unvaccinated group. Specifically, the vaccination program is associated with an absolute risk reduction of $0.02175$ (or $2.175$ cases per $100$ person-years) in a population with the specified age structure. This provides evidence for a protective effect of the vaccine.", "answer": "$$\\boxed{-0.02175}$$", "id": "4549025"}, {"introduction": "An alternative to post-hoc statistical adjustment is to create comparable groups at the analysis stage through matching. However, how do we know if our matching procedure was successful? This exercise introduces the Standardized Mean Difference (SMD), a crucial diagnostic tool for assessing covariate balance. By calculating the SMD before and after matching using hypothetical summary statistics, you will learn to quantify the success of your confounding control strategy and ensure your groups are truly comparable [@problem_id:4549004].", "problem": "An observational cohort study in preventive medicine evaluates the association between participation in a workplace lifestyle program (treated group) and subsequent incidence of metabolic syndrome (control group is non-participants). To control for confounding, investigators perform one-to-one nearest neighbor matching without replacement on measured covariates. To assess covariate balance, they plan to use the Standardized Mean Difference (SMD), with acceptable post-matching balance defined by the threshold $\\text{SMD}  0.1$.\n\nYou are given summary statistics for two continuous confounders commonly controlled for in preventive medicine—age and body mass index (BMI)—before and after matching. For each confounder, the summaries include the treated group mean and standard deviation, and the control group mean and standard deviation.\n\nBefore matching:\n- Age: treated mean $58.0$, treated standard deviation $7.5$; control mean $52.0$, control standard deviation $8.0$.\n- BMI: treated mean $28.5$, treated standard deviation $4.2$; control mean $26.0$, control standard deviation $4.0$.\n\nAfter matching:\n- Age: treated mean $56.5$, treated standard deviation $7.0$; control mean $56.0$, control standard deviation $7.1$.\n- BMI: treated mean $27.8$, treated standard deviation $4.1$; control mean $27.6$, control standard deviation $4.2$.\n\nTasks:\n1. Starting from the core idea of standardization and the definition of pooled variance in two-group comparisons, formally define the Standardized Mean Difference (SMD) for a continuous confounder when assessing balance between treated and control groups.\n2. Using this definition, compute the SMD for age and BMI both before and after matching, and state whether each confounder meets the acceptable balance threshold $\\text{SMD}  0.1$ after matching.\n3. Report, as a single numeric value, the largest absolute SMD among the two confounders after matching. Round your final answer to four significant figures. Express the final answer as a pure number without any unit.", "solution": "**1. Formal Definition of the Standardized Mean Difference (SMD)**\n\nThe Standardized Mean Difference (SMD) is a scale-free measure used to quantify the magnitude of the difference between the means of two groups. It is defined as the absolute difference in sample means divided by a pooled standard deviation. For assessing balance after one-to-one matching, where group sizes are equal, the pooled standard deviation formula simplifies to $\\sqrt{(s_T^2 + s_C^2)/2}$. For assessing balance before matching, where sample sizes are often unequal and may not be provided, this same formula serves as a standard approximation. For consistency in this problem, we will use the following definition for all calculations:\n$$ \\text{SMD} = \\frac{|\\bar{x}_T - \\bar{x}_C|}{\\sqrt{\\frac{s_T^2 + s_C^2}{2}}} $$\n\n**2. Computation of SMD and Assessment of Balance**\n\nWe compute the SMD for each confounder, before and after matching, using the formula above.\n\n**Before Matching:**\n\n- **Age:**\n  $$ \\text{SMD}_{\\text{Age, before}} = \\frac{|58.0 - 52.0|}{\\sqrt{\\frac{(7.5)^2 + (8.0)^2}{2}}} = \\frac{6.0}{\\sqrt{\\frac{56.25 + 64.0}{2}}} = \\frac{6.0}{\\sqrt{60.125}} \\approx 0.773805 $$\n\n- **BMI:**\n  $$ \\text{SMD}_{\\text{BMI, before}} = \\frac{|28.5 - 26.0|}{\\sqrt{\\frac{(4.2)^2 + (4.0)^2}{2}}} = \\frac{2.5}{\\sqrt{\\frac{17.64 + 16.0}{2}}} = \\frac{2.5}{\\sqrt{16.82}} \\approx 0.609575 $$\nAs expected, the initial balance is poor, with large SMDs for both confounders.\n\n**After Matching:**\n\n- **Age:**\n  $$ \\text{SMD}_{\\text{Age, after}} = \\frac{|56.5 - 56.0|}{\\sqrt{\\frac{(7.0)^2 + (7.1)^2}{2}}} = \\frac{0.5}{\\sqrt{\\frac{49.0 + 50.41}{2}}} = \\frac{0.5}{\\sqrt{49.705}} \\approx 0.070920 $$\n  The calculated SMD for age after matching is approximately $0.0709$. Since $0.0709  0.1$, the confounder age meets the acceptable balance threshold after matching.\n\n- **BMI:**\n  $$ \\text{SMD}_{\\text{BMI, after}} = \\frac{|27.8 - 27.6|}{\\sqrt{\\frac{(4.1)^2 + (4.2)^2}{2}}} = \\frac{0.2}{\\sqrt{\\frac{16.81 + 17.64}{2}}} = \\frac{0.2}{\\sqrt{17.225}} \\approx 0.048189 $$\n  The calculated SMD for BMI after matching is approximately $0.0482$. Since $0.0482  0.1$, the confounder BMI meets the acceptable balance threshold after matching.\n\n**3. Report the Largest Post-Matching SMD**\n\nThe largest absolute SMD among the two confounders after matching is for age. The problem requires this value to be rounded to four significant figures. The calculated value is $0.070920...$, which rounds to $0.07092$.", "answer": "$$\\boxed{0.07092}$$", "id": "4549004"}]}